Literature DB >> 17351878

[What makes "Head-and-Neck-Cancers" recur: Tumorinvasion "revisited"].

C Simon1, A Koitschev, P K Plinkert.   

Abstract

Head and neck squamous cell carcinomas (HNSCC) are common cancers with a relatively poor prognosis. Locoregionale recurrences are regularly encountered and associated with a detrimental outcome. Studies of the last few years report that not only tumor staging and grading influence locoregional control but also histologic and biological markers. One such histological marker is coined "worst pattern of invasion". It describes a histologic growth pattern consisting of invading tumor cell islands and strands that are dispatched from the invasion front (POI typ 4 and 5). Additional features of invasion are perineural invasion and extracapsular nodal extension. Besides histological markers there are molecular characteristics that include the expression of gene families involved in extracellular matrix degradation. The data suggest that head and neck cancers differ with respect to their invasive growth capacity and thus their ability to generate locoregionale recurrences. It appears that locoregionale control is a consequence of this growth pattern. This may explain, why in recent clincial studies the prognostic marker "pattern-of-invasion" outweights even such well established prognosticators such as "surgical margins".

Entities:  

Mesh:

Year:  2007        PMID: 17351878     DOI: 10.1055/s-2007-966162

Source DB:  PubMed          Journal:  Laryngorhinootologie        ISSN: 0935-8943            Impact factor:   1.057


  2 in total

1.  [Incidence, latency, and prognosis of local and regional recurrences in patients with upper aerodigestive tract cancer treated by laser microsurgery: influence of initial tumor parameters].

Authors:  M C Jäckel; A Martin; W Steiner
Journal:  HNO       Date:  2007-12       Impact factor: 1.284

2.  Perineural spread of malignant head and neck tumors: review of the literature and analysis of cases treated at a teaching hospital.

Authors:  Mauro César Silveira Moreira; Antonio Carlos Dos Santos; Murilo Bicudo Cintra
Journal:  Radiol Bras       Date:  2017 Sep-Oct
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.